Thanks to recent technological advancements, investing in stocks is more accessible than ever.
But choosing the right stock to buy?
That’s a whole different story. Without a solid investment strategy, becoming a successful trader is nearly impossible. After running a fundamental analysis on stocks from various industries, our experts have identified 11 companies that you can consider adding to your investment portfolio.
Our list includes blue-chip companies from the tech and banking sector and diversification stocks from two emerging industries: gambling and biotech.
Be aware: Things can quickly change in the stock prices thanks to market volatility. Invest at your own risk.
Without further ado, here are the top stocks to buy right now:
Top 3 stocks you should buy
After the inflation data surfaced, the news in May announcing that the Consumer Price Index(CPI) rose by 4.2% from the year before, the picture couldn’t be more straightforward for us.
Based on the fact that the CPI report was the highest 12-month rise since 2008 and the real-estate prices soared, the stock market shows signs of rallying.
However, don’t base your investment decisions solely on this data. The FED may increase the interest rates soon to deal with inflation. Until the market fully recovers from the bearish trend, you need to be extra careful with your acquisitions.
Right now, these 5 top gainers that can potentially bring you a solid return are:
Google’s parent company, Alphabet is in a good buying zone right now as the price is staging a recovery of the 10-week line. Not to mention that they recently announced that they would roll over a new update to their AI, which is capable of natural language processing.
Investing in any stock is risky. However, the Alphabet company brings a lot of arguments that can lower that risk.
First off, Google owns the internet’s largest search engine, Youtube, the most popular entertainment platform and a good part of the cloud computing sector.
Another noteworthy fact is that last quarter. The company reported a 34% revenue increase, which is impressive, considering that Alphabet is worth over $1.6 trillion. The growth of video marketing has also been beneficial for the tech giant, as Youtube announced 48.7% year-on-year revenue growth to $6 billion.
Buying Alphabet stocks is a no-brainer for any tech-savvy person.
After all, most businesses (especially online-based ones) would suffer from massive revenue decreases if something happened to Google. Thus, you can consider investing in Alphabet for the long run, not just for short-term gains.
Goldman Sachs (GS)
Goldman Sachs has benefitted from the large number of investors that entered the markets during the Reddit short squeeze, that added increased market volatility to the mix.
Right now, Goldman Sachs prices stand at the top of the buy zone after breaking out of the “cup” base. The price stands a little over $377, which in our opinion, is an actionable entry. In the last quarter, the company’s investment banking revenue increased by 73%, reaching an all-time high of $3.77 billion.
The fixed-income trading revenue also surged by 31, and the equities trading revenue exploded by 68%, reaching $3.69 billion.
Leaving aside the massive revenue growth that Goldman Sachs reported last quarter, the company also pays low dividends (1.4%), which uses only 12% of its total earnings. That’s unusual for a bank since most other players in the market are known for paying huge dividends.
The low dividend strategy leaves the door open for a payout raise in the coming years. Even though their main competitor, JPMorgan Chase, is four times larger in terms of revenue, Goldman Sachs is a solid investment with a good return in the long run.
The Nvidia stock has a new promising entry point at $648.6 after breaking out of the cup base during a heavy volume period.
The new base spent more time on the 10-week line than the previous one, and it is staged for recovery after finding its support at the 50-week line. That’s also thanks to the 4 for one stock split announcement, which resulted in an all-time high after the earnings report.
Right now, Nvidia is in the sustained growth phase, which is mainly thanks to the great sales of their GeForce Laptop GPU system, where they compete against AMD’s Radeon. Nvidia regularly beats AMD in the laptop battle, which offered them massive growth over the last two years.
Nvidia is not just a gamer-oriented business.
They are a revolutionary tech company that powers most of the advanced electronics, including crypto mining rigs. As cryptocurrency continues to rise in popularity, so will the company, since they are selling dedicated mining video cards (CMP) contributing to the coin market cap.
Overall, investing in Nvidia right now it’s great because its technology will continue to be essential for the constantly increasing complexity of GPU requirements for mining crypto or running specific software. Like with all the stocks mentioned so far, we suggest going long on this one since the company isn’t going away anytime soon.
Casino affiliates stocks
You already know that affiliate marketing is an efficient promotion technique that involves getting paid a commission for every sale you make.
But did you know that you can invest in affiliate marketing stocks?
Here’s how it works:
One of the most lucrative industries for affiliate marketing is online gambling. That’s mainly because paid advertising in the casino industry is relatively expensive or prohibited. But marketers have found a “loophole” to advertise their product:
- They create a review website with bonuses;
- Then, they reach out to the casinos and negotiate the commission value;
- Finally, the affiliate marketer writes an in-depth review and details about the best promotions available;
Once the company is listed on the affiliate platform, visitors of the site will claim any of their promotions. If the user decides to create an account and deposit, the affiliate is paid a commission. We can call it a win-win situation.
In the beginning, the casino affiliate marketing platforms were more of a family side-business type of thing. However, as the iGaming industry surged, so did the demand for casino bonuses, making the affiliate business a lot more competitive and profitable.
This is how the super-affiliates were born.
These companies are listed on the world’s largest stock exchanges, and you can buy a share right now. Affiliate stocks are great because they have much larger scalability than a regular casino stock since they are literally driving traffic to all gambling platforms available online.
Let’s explore two of the best casino affiliate stocks you can invest in:
Catena Media (CTM)
Catena Media is a PLC know for owning the most prominent casino affiliate forum in the world. They currently have 390 employees in their offices in 9 countries, including the UK, Malta, Germany, Japan and the US.
Over the years, Catena Media has revolutionized the market by creating a player complaint system, where gamblers can review the casinos based on their experience.
This feature added a lot of trust to the product, which boosted its rankings in the search engine. (especially since gamblers tend to be transparent in their reviews). Thanks to the consistency of their traffic, the company reached a market cap of almost 5 billion, and it currently trades above $66.
The investment in Catena Media stocks is a good choice in the long run for diversification. That’s because aside from the constant growth of the online gambling market, the group is currently focusing on a new product called Ask Traders, an affiliate site that deals with online trading platform reviews.
XLmedia had its IPO back in 2013. Their revenue in the previous year is estimated to $34.56 million, thanks to the acquisition of multiple smaller affiliates that added a lot of value to their business. They are the first super affiliates listed on the London Stock Exchange.
Their stock prices have been underperforming recently, mainly thanks to the competition catching them from behind. However, the group owns thousands of websites and operates in over 23 countries.
Consider investing in XLMedia, since they are announcing new sports betting products, potentially taking them to the top of the list. But be aware, since the affiliate marketing business can fluctuate thanks to Google updates.
If you’re not familiar with how the Google Search Engines work, you should consider spending some time understanding it before investing in the XLMedia stock.
Biotechnology is quickly becoming the norm in medicine. The age of nanobots and cancer healing innovation is just around the corner.
Scientists are starting to realize that technology can potentially be integrated with the human body to help identify or eliminate certain diseases. Still, when you consider investing in a biotech company, you have to focus on the future.
Also, understand that most biotech companies are new on the market, so their value is not as high as the tech giants mentioned above. Th
Let’s explore two of the most prominent biotech companies that you can invest in right now:
Exelixis is known for its flagship molecule called cabozantinib. They sell the drug under Cabometyx, which is great for hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC), and Cometriq for thyroid cancer.
The cabozantinib works as a blocker for tyrosine kinases, an enzyme that has a role in developing cancer. This makes the substance extremely valuable, as it could expand to treatment for various types of cancers.
This year, the FDA approved using a combination of Cabometyx and Opdivo as the primary treatment for advanced RCC. Exelixis declared that they are currently running 70 clinical trials that should identify a wide range of new uses for the substance.
Their annual revenue massively increased over the past five years, mainly thanks to discovering the innovative substance cabozantinib. This year, they expect to surpass the $1 billion mark. Our analysis shows the potential of a 39% increase over the next 12 months, based on the Wall Street average estimation.
Bristol Myers Squibb (BMY)
With a market value of $146.5 billion, Bristol Myers Squibb is the leading biotech and anti-cancer company right now. Their oncology drugs and their revolutionary cancer treatments Opdivo, Yerovy, Revlimid and Pomalyst account for 66% of their total revenues (over $27 billion last year).
The company is continually innovating the biotech market. However, their sales for their flagship product Opdivo have decreased 3% year on year, mainly because of the release of the revolutionary drug Keytruda created by Merck.
Overall, the BMY stock is an excellent choice for portfolio diversification since it will continue growing in the long run, mainly thanks to FDA’s announcement that they’re considering allowing Opdivo for adjuvant therapy for muscle-invasive urothelial carcinoma. Physician checks have shown that between 2025 and 2028, the sales of Opdivo will increase by $3.5 billion.
When the patent expires in 2028, the revenue will reach an $11 billion peak.
Now it’s your turn
Investing in stock requires the perfect balance between reading news and fundamental analysis.
While trading is a tough job, we are experts that are willing to share our research results with you. However, you should not blindly invest money in these stocks just because we consider them great.
Instead, take some time and do some digging on the company and find out whether their plans align with your interests and you consider them valuable.
Once you’re done, start analyzing the historical market data and identify a pattern that can lead to a solid investment decision.
Let us know if you need any guidance with choosing the right stock.